BAG Montpellier

The BAG of Montpellier gathers researchers from distinct institutes (CBS, IGF, IRIM and LPHI) affiliated to the INSERM, the CNRS
and the university of Montpellier.
The CBS is a node of the national infrastructure FRISBI. In this context, it is developping new methodologies for efficient ligand screening by
X-ray diffraction. It is also involved in solving the structure of novel therapeutic targets to develop novel drug candidates.
The IGF is involved in characterizing membrane proteins (mainly GPCRs) in order to better understand their functioning for therapeutic
application.
The IRIM and LPHI are focusing on several therapeutic targets related to infectious diseases in order to identify and develop novel inhibitors.

蒙彼利埃BAG汇集了隶属于法国国家健康与医学研究院（INSERM）、法国国家科学研究中心（CNRS）以及蒙彼利埃大学的多家不同研究所的研究人员，涵盖CBS、IGF、IRIM与LPHI四家单位。

CBS作为国家基础设施FRISBI的节点单位，在此框架下正开发基于X射线衍射的高效配体筛选新方法，同时还致力于解析新型治疗靶点的结构，以研发全新的候选药物。

IGF的研究方向为膜蛋白（主要为G蛋白偶联受体（GPCRs））的特性表征，以期深入阐明其功能机制并服务于治疗应用。

IRIM与LPHI则聚焦于与传染病相关的多项治疗靶点，旨在识别并开发新型抑制剂。